Measures AQP4-IgG and MOG-IgG antibodies associated with autoimmune central nervous system demyelinating disorders.
Used to investigate optic neuritis, transverse myelitis and related presentations, helping distinguish AQP4-positive NMOSD from MOG antibody-associated disease.